AN ACT to amend the public health law, in relation to adult immunization reporting requirements
AN ACT to amend the public health law, in relation to adult immunization reporting requirements
The Climate Change and Health Adaptation Resource Guide is designed to empower local health departments (LHDs) in their efforts to address the complex intersections of climate change and public health. Originally developed during the Fall 2022 Climate and Health Adaptation Workshops, this guide has since become a comprehensive, evolving resource that will be updated as needed.
Packed with actionable insights, case studies, resource hubs, toolkits, and funding opportunities, the guide serves as a vital tool for LHDs to navigate challenges such as extreme heat, vector-borne diseases, and weather-related health impacts. It supports climate change adaptation efforts, fosters cross-sector collaboration, and promotes resilience in communities across New York State.
Your feedback and contributions are invaluable! If you have resources to share, updates to suggest, or notice any issues, please reach out to Danielle Pellino at [email protected].
The goal of the Model Overdose Reversal Agents Act is to provide a template of suggested legislative provisions that gives legislators and policymakers the means to expand access to ORAs in the state and, thus, save more lives. This Act is comprehensive and enables legislators to completely replace any existing ORA laws with this Act or use individual provisions that best address the needs of the state.
In response to increasing overdose fatality rates, states have passed legislation to increase access to the opioid overdose reversal medication naloxone, including provisions that allow for the distribution of naloxone through pharmacies. Some states have gone further and now require that naloxone be prescribed or offered to some patients. This fact sheet describes those requirements and links to the relevant laws as of 2024.
Policies varied between four states highly impacted by opioid overdose fatalities. Policies were dynamic and moved towards greater naloxone access. These four states have developed innovative but different policy responses. Naloxone research and practice should consider the policy landscape of a state.